Eight minor cannabinoids showed activity at CB1 and CB2 receptors in cells and produced cannabinoid-like effects in mice

What the researchers found

THC, THCA, THCV, CBD, CBDA, CBDV, CBG, and CBC were tested for receptor binding, cAMP inhibition, beta-arrestin2 recruitment, and in vivo effects. Multiple minor cannabinoids displayed partial agonist activity at CB1 and/or CB2. Several produced cannabinoid-like tetrad effects in mice (catalepsy, hypothermia, antinociception, hypolocomotion) and anxiolytic-like effects.

Why it matters

Most cannabis research focuses on THC and CBD, but cannabis contains over 120 cannabinoids. Understanding the pharmacology of minor compounds is essential for explaining whole-plant effects and developing targeted therapeutics.

The numbers in context

8 phytocannabinoids tested. Multiple showed partial CB1R and/or CB2R agonist activity. In vivo tetrad effects and anxiolytic responses observed for several compounds.

How the study worked

In vitro: CHO cells stably expressing human CB1R or CB2R tested for binding affinity, cAMP inhibition, beta-arrestin2 recruitment, and ligand bias. In vivo: C57BL/6 mice tested in the cannabinoid tetrad battery and elevated plus maze for anxiety.

What this study cannot tell us

In vitro studies used overexpression cell systems that may not reflect physiological receptor levels. Mouse behavioral tests provide limited insight into human effects. Compounds were tested individually, not in combination as they occur in plant material.

How to read the evidence

Comprehensive in vitro characterization with in vivo validation, but preclinical data only. Overexpression systems may amplify receptor activity.

When this study was published

2020 study. One of the most comprehensive pharmacological characterizations of minor phytocannabinoids to date.

The bigger picture

The finding that many minor cannabinoids have their own receptor activity supports the "entourage effect" concept and suggests that the therapeutic potential of cannabis extends well beyond THC and CBD.

Questions still open

• How do these minor cannabinoids interact with each other and with THC/CBD in combination? Could specific minor cannabinoids be developed as standalone therapeutics? Do the receptor selectivity profiles predict which compounds might be useful for specific conditions?

Common questions

Read the original research

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.

Scientific reports, 10(1), 20405

Citation

Zagzoog, Ayat; Mohamed, Kawthar A; Kim, Hye Ji J; Kim, Eunhyun D; Frank, Connor S; Black, Tallan; Jadhav, Pramodkumar D; Holbrook, Larry A; Laprairie, Robert B. (2020). In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.. Scientific reports, 10(1), 20405. https://doi.org/10.1038/s41598-020-77175-y

Explore the wider topic

• How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
• The Anandamide Connection: Your Body's Natural Bliss Molecule
• How Long for Cannabinoid Receptors to Return to Normal
• Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
• Why Can't I Enjoy Anything Without Weed? The Science Behind It
• Dopamine Recovery After Quitting Weed: What the Science Says
• The Endocannabinoid System Explained Simply: What It Does and Why It Matters
• Your Endocannabinoid System Explained: Why Withdrawal Happens
• Your Nervous System After Quitting Weed: Fight or Flight
• Using Weed Under 18: What It Does to Your Developing Brain
• What THC Does to Your Brain: Why Withdrawal Happens
• THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
• Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
• Weed and Memory: What the Science Says About THC and Your Hippocampus
• Weed and Motivation: Is Amotivational Syndrome Real?
• Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
• How Weed Rewires Your Reward System (And How to Reset It)